318 related articles for article (PubMed ID: 37664153)
1. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.
Zhang MH; Yuan YF; Liu LJ; Wei YX; Yin WY; Zheng LZ; Tang YY; Lv Z; Zhu F
World J Gastroenterol; 2023 Aug; 29(31):4706-4735. PubMed ID: 37664153
[TBL] [Abstract][Full Text] [Related]
2. Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC.
Xu F; Meng Q; Wu F; Wang Y; Yang W; Tong Y; Liu L; Chen X
Oxid Med Cell Longev; 2022; 2022():3472179. PubMed ID: 36105485
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus and microRNAs: A Bioinformatics Approach.
Zulian V; Fiscon G; Paci P; Garbuglia AR
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139051
[TBL] [Abstract][Full Text] [Related]
4. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
Zhou Y; Liu F; Ma C; Cheng Q
J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study.
Sartorius K; Sartorius B; Winkler C; Chuturgoon A; Shen TW; Zhao Y; An P
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256049
[TBL] [Abstract][Full Text] [Related]
6. miRNAs as Potential Biomarkers for Viral Hepatitis B and C.
Loureiro D; Tout I; Narguet S; Benazzouz SM; Mansouri A; Asselah T
Viruses; 2020 Dec; 12(12):. PubMed ID: 33327640
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets.
Xu J; An P; Winkler CA; Yu Y
Front Oncol; 2020; 10():1271. PubMed ID: 32850386
[TBL] [Abstract][Full Text] [Related]
9. Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells.
Todorova VK; Byrum SD; Mackintosh SG; Jamshidi-Parsian A; Gies AJ; Washam CL; Jenkins SV; Spiva T; Bowman E; Reyna NS; Griffin RJ; Makhoul I
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685904
[TBL] [Abstract][Full Text] [Related]
10. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.
Pezzuto F; Buonaguro L; Buonaguro FM; Tornesello ML
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29597259
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles Contribute to Viral-Induced Hepatocellular Carcinoma: Understanding Their Involvement in Viral Hepatitis and Their Potential as Biomarkers for Early Hepatocellular Carcinoma Detection.
Tahir F; Farooq M; Malik MA; Manzoor S
Viral Immunol; 2024 Apr; 37(3):159-166. PubMed ID: 38588555
[TBL] [Abstract][Full Text] [Related]
12. Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay.
Zhang S; Jiang C; Jiang L; Chen H; Huang J; Gao X; Xia Z; Tran LJ; Zhang J; Chi H; Yang G; Tian G
Tumour Virus Res; 2023 Dec; 16():200271. PubMed ID: 37774952
[TBL] [Abstract][Full Text] [Related]
13. microRNAs in liver disease: from diagnostics to therapeutics.
Takahashi K; Yan I; Wen HJ; Patel T
Clin Biochem; 2013 Jul; 46(10-11):946-52. PubMed ID: 23396165
[TBL] [Abstract][Full Text] [Related]
14. Gene variation profile and the potential correlation with clinical characteristics in HBV-associated HCC.
Lu P; Liu Z
Asian J Surg; 2024 Jan; 47(1):788. PubMed ID: 37957044
[No Abstract] [Full Text] [Related]
15. Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Zeng Y; Hu S; Luo Y; He K
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765333
[TBL] [Abstract][Full Text] [Related]
16. Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma.
Yao M; Wang L; Yao Y; Gu HB; Yao DF
J Clin Transl Hepatol; 2014 Dec; 2(4):253-8. PubMed ID: 26355266
[TBL] [Abstract][Full Text] [Related]
17. MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
Jouve M; Carpentier R; Kraiem S; Legrand N; Sobolewski C
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067261
[TBL] [Abstract][Full Text] [Related]
18. Genetic Alchemy unveiled: MicroRNA-mediated gene therapy as the Artisan craft in the battlefront against hepatocellular carcinoma-a comprehensive chronicle of strategies and innovations.
Murshed A; Alnoud MAH; Ahmad S; Khan SU; Alissa M; Alsuwat MA; Ahmed AE; Khan MU
Front Genet; 2024; 15():1356972. PubMed ID: 38915826
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma.
Dong JM; Wang RQ; Yuan NN; Guo JH; Yu XY; Peng AH; Cai JY; Xue L; Zhou ZL; Sun YH; Chen YY
Front Cell Dev Biol; 2023; 11():1160544. PubMed ID: 37143897
[TBL] [Abstract][Full Text] [Related]
20. The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery.
Shen EY; U MRA; Cox IJ; Taylor-Robinson SD
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
